Sponsor Pipeline

Liping Dou Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
6
Active Trials
4
Recruiting
3
Disease Areas
Active Trials by Phase
Phase 2
2
Phase 1/2
2
Phase 1
1
Early Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07587840 CD19/CD22 CAR-T as First-line Consolidation in Follicular Lymphoma Lymphoma Recruiting
NCT07651475 Study of the Beach Regimen on Relapsed/Refractory Acute Myeloid Leukemia (R/R AML) R/R AML Active, Not Recruiting
Phase 1/2
NCT07575919 Targeted CD22/CD19 CAR-T Therapy for Consolidation in Standard-Risk B-ALL B-cell Acute Lymphoblastic Leukemia Recruiting
NCT07575971 Exploratory Study of CD22/CD19 Dual-Target CAR-T Cell Therapy as Consolidation Treatment… B-cell Acute Lymphoblastic Leukemia Recruiting
Phase 1
NCT07677878 Blinatumomab Combined With Low-dose DLI as Maintenance Therapy After Transplantation for… ALL (Acute B-Lymphoblastic Leukemia) Recruiting
Early Phase 1
NCT07586709 In Vivo BCMA/GPRC5D Tandem Dual CAR-T Therapy for Relapsed/Refractory Plasma Cell… Plasma Cell Neoplasms Not Yet Recruiting
Disease Areas
Get alerts when Liping Dou's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free